Aurobindo Pharma gets FDA nod for generic Omnicef
Aurobindo Pharma Ltd., headquart
ered in India, has received FDA approval to market the 300mg strength of its Cefdinir capsules in the US. Cefdinir is a generic version of Abbott Laboratories’ Omnicef, which is used to treat or prevent bacterial infections. According to IMS Health, Omnicef sales totaled about $787 million in 2006. Aurobindo Pharma already has FDA approval to market the 125mg and 250mg strengths of Cefdinir capsules.
- APP receives FDA nod for its two generics
- Barr Pharma receives FDA nod for generic Mirapex
- Barr Labs receives FDA nod for generic Yasmin
- Mylan receives FDA nod for generic Plendil
